Nonsteroidal anti-inflammatory drugs for dysmenorrhoea (Q24240980)

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Use of Mefenamic Acid in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Ketoprofen, ibuprofen, and placebo in the treatment of primary dysmenorrhea: a double-blind crossover comparison.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Treating dysmenorrhea with anti-inflammatory agents: a double-blind trial with naproxen sodium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Treatment of Primary Dysmenorrhea with Mefenamic Acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Comparison of the Efficacy and Tolerability of Dexketoprofen and Ketoprofen in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Indomethacin in the treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Clinical use and pharmacological properties of selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Flurbiprofen for the treatment of primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

A double-blind, placebo-controlled study comparing three single-dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Anaprox in dysmenorrhea: Reduction of pain and intrauterine pressure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Naproxen sodium in uterine pain following intrauterine contraceptive device insertion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The objective evaluation of dysmenorrhea therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The uterine contractility index: A research and diagnostic tool in dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Ibuprofen and naproxen-sodium in the treatment of primary dysmenorrhea: a double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Treatment of primary dysmenorrhea with diclofenac sodium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Tiaprofenic acid in the treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine “jet-washings” in dysmenorrehic women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The relief of primary dysmenorrhea by ketoprofen and indomethacin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Prostaglandin biosynthesis inhibitors and endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Comparison between naproxen tablets and suppositories in primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Severe, primary dysmenorrhea treated with naproxen. A prospective, double-blind, crossover investigation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Comparison between fluproquazone and indomethacin in treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The influence of anxiety and locus of control on adolescents' response to naproxen sodium for mild to moderate pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Diflunisal compared with naproxen in the treatment of dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Objective changes in intrauterine pressure during placebo treatment of dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Dynamics and significance of placebo response in primary dysmenorrhea.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Effect of a Psidii guajavae folium extract in the treatment of primary dysmenorrhea: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Diclofenac potassium attenuates dysmenorrhea and restores exercise performance in women with primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Ibuprofen and dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Simultaneous objective and subjective evaluation of meclofenamate sodium in the treatment of primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Analgesia with ibuprofen arginate versus conventional ibuprofen for patients with dysmenorrhea: a crossover trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Dysmenorrhea treatment with a single daily dose of rofecoxib

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The effect of aspirin on dysmenorrhea in adolescents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Naproxen in dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Differential response by adolescents to naproxen sodium therapy for spasmodic and congestive dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Flurbiprofen in dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Zomepirac sodium in the treatment of primary dysmenorrhea syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

A crossover comparison of bromfenac sodium, naproxen sodium, and placebo for relief of pain from primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Efficacy and tolerability of lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Meta-analyses involving cross-over trials: methodological issues

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Comparative Efficacy of Ibuprofen, Indomethacin, and Placebo in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Primary dysmenorrhea: advances in pathogenesis and management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The effect of three cyclo-oxygenase inhibitors on intensity of primary dysmenorrheic pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Flurbiprofen in the treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Menstrual blood loss in dysmenorrhoea: effects of proquazone and indomethacin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Effect of ibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Ibuprofen is a useful treatment for primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

A comparison of tiaprofenic acid, mefenamic acid and placebo in the treatment of dysmenorrhoea in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Tolfenamic acid and mefenamic acid in the treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Analgesic efficacy of etoricoxib in primary dysmenorrhea: results of a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

ADIDAC trial: analgesia with dexibuprofen versus ibuprofen in patients suffering from primary dysmenorrhea: a crossover trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Effect of small doses of aspirin and acetaminophen on total menstrual loss and pain of cramps and headache

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Do aspirin and acetaminophen affect total menstrual loss?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

‘Buscopan’ in spasmodic dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Comparison of ketoprofen and naproxen in the treatment of dysmenorrhoea, with special regard to the time of onset of pain relief

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Treatment of Primary Dysmenorrhea with Prostaglandin Synthetase Inhibitors—a Promising Therapeutic Alternative

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Prostaglandins and Dysmenorrhea Historical survey

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The Effect of Inhibitors of Prostaglandin Synthesis in Primary Dysmenorrhea Studied with Hysterometry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Endogenous Prostaglandins in Dysmenorrhea and the Effect of Prostaglandin Synthetase Inhibitors (PGSI) on Uterine Contractility

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Prostaglandin Synthetase Inhibitors and Dysmenorrhea: A Survey and Personal Clinical Experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Effect of Acetylsalicylic Acid, Paracetamol and Placebo on Pain and Blood Loss in Dysmenorrheic Women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Naproxen and Indomethacin in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Suppression of Menstrual Prostaglandins and Relief of Dysmenorrhea with Ibuprofen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Clinical Experience of Naproxen in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Naproxen and Naproxen Sodium in Dysmenorrhea: Development from in vitro Inhibition of Prostaglandin Synthesis to Suppression of Uterine Contractions in Women and Demonstration of Clinical Efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Piroxicam in the treatment of primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

A comparative crossover study of piroxicam vs. mefenamic acid and diclofenac in France

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

Piroxicam in primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001751.PUB2

7 January 2021

10.1002/14651858.CD001751.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1821559

OpenCitations bibliographic resource ID

1821559

1 reference